| 000 | 01766 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250516192419.0 | ||
| 264 | 0 | _c20140527 | |
| 008 | 201405s 0 0 eng d | ||
| 022 | _a1879-0852 | ||
| 024 | 7 |
_a10.1016/j.ejca.2013.12.015 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGaudy-Marqueste, Caroline | |
| 245 | 0 | 0 |
_aInitial metastatic kinetics is the best prognostic indicator in stage IV metastatic melanoma. _h[electronic resource] |
| 260 |
_bEuropean journal of cancer (Oxford, England : 1990) _cApr 2014 |
||
| 300 |
_a1120-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xmetabolism |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 |
_aL-Lactate Dehydrogenase _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMelanoma _xdrug therapy |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aTumor Burden |
| 650 | 0 | 4 |
_aWatchful Waiting _xmethods |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aArchier, Elodie | |
| 700 | 1 | _aGrob, Anaïs | |
| 700 | 1 | _aDurieux, Olivier | |
| 700 | 1 | _aLoundou, Anderson | |
| 700 | 1 | _aRichard, Marie-Aleth | |
| 700 | 1 | _aGrob, Jean-Jacques | |
| 773 | 0 |
_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 50 _gno. 6 _gp. 1120-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejca.2013.12.015 _zAvailable from publisher's website |
| 999 |
_c23463354 _d23463354 |
||